A citation-based method for searching scientific literature

Carin A T C Lunenburg, Janne P Thirstrup, Jonas Bybjerg-Grauholm, Marie Bækvad-Hansen, David M Hougaard, Merete Nordentoft, Thomas Werge, Anders D Børglum, Ole Mors, Preben B Mortensen, Christiane Gasse. Transl Psychiatry 2021
Times Cited: 3







List of co-cited articles
7 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Longitudinal exposure of English primary care patients to pharmacogenomic drugs: An analysis to inform design of pre-emptive pharmacogenomic testing.
James E Kimpton, Iain M Carey, Christopher J D Threapleton, Alexandra Robinson, Tess Harris, Derek G Cook, Stephen DeWilde, Emma H Baker. Br J Clin Pharmacol 2019
12
66

Association of CYP2C19 and CYP2D6 Poor and Intermediate Metabolizer Status With Antidepressant and Antipsychotic Exposure: A Systematic Review and Meta-analysis.
Filip Milosavljevic, Nikola Bukvic, Zorana Pavlovic, Cedo Miljevic, Vesna Pešic, Espen Molden, Magnus Ingelman-Sundberg, Stefan Leucht, Marin M Jukic. JAMA Psychiatry 2021
25
66


Prediction of response to drug therapy in psychiatric disorders.
Shani Stern, Sara Linker, Krishna C Vadodaria, Maria C Marchetto, Fred H Gage. Open Biol 2018
30
66

Precision medicine in 2030-seven ways to transform healthcare.
Joshua C Denny, Francis S Collins. Cell 2021
50
66

Pharmacogenetics: from bench to byte.
J J Swen, I Wilting, A L de Goede, L Grandia, H Mulder, D J Touw, A de Boer, J M H Conemans, T C G Egberts, O H Klungel,[...]. Clin Pharmacol Ther 2008
159
66

Review and Consensus on Pharmacogenomic Testing in Psychiatry.
Chad A Bousman, Susanne A Bengesser, Katherine J Aitchison, Azmeraw T Amare, Harald Aschauer, Bernhard T Baune, Bahareh Behroozi Asl, Jeffrey R Bishop, Margit Burmeister, Boris Chaumette,[...]. Pharmacopsychiatry 2021
39
66

CYP2D6 Phenotype Influences Aripiprazole Tolerability in Pediatric Patients with Mood Disorders.
Sahar A Jallaq, Mark Verba, Jeffrey R Strawn, Lisa J Martin, Melissa P DelBello, Laura B Ramsey. J Child Adolesc Psychopharmacol 2021
5
33

Use of antidepressants with pharmacogenetic prescribing guidelines in a 10-year depression cohort of adult primary care patients.
Chaten D Jessel, Sam Mostafa, Maria Potiriadis, Ian P Everall, Jane M Gunn, Chad A Bousman. Pharmacogenet Genomics 2020
4
33

Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomized controlled trials.
Chad A Bousman, Katarina Arandjelovic, Serafino G Mancuso, Harris A Eyre, Boadie W Dunlop. Pharmacogenomics 2019
80
33


HLA-B38, DR4, DQw3 and clozapine-induced agranulocytosis in Jewish patients with schizophrenia.
J A Lieberman, J Yunis, E Egea, R T Canoso, J M Kane, E J Yunis. Arch Gen Psychiatry 1990
191
33

PharmGKB: A worldwide resource for pharmacogenomic information.
Julia M Barbarino, Michelle Whirl-Carrillo, Russ B Altman, Teri E Klein. Wiley Interdiscip Rev Syst Biol Med 2018
107
33

Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).
Peter B Jones, Thomas R E Barnes, Linda Davies, Graham Dunn, Helen Lloyd, Karen P Hayhurst, Robin M Murray, Alison Markwick, Shôn W Lewis. Arch Gen Psychiatry 2006
742
33

Is response to prophylactic lithium a familial trait?
Paul Grof, Anne Duffy, Patrizia Cavazzoni, Eva Grof, Julie Garnham, Marsha MacDougall, Claire O'Donovan, Martin Alda. J Clin Psychiatry 2002
243
33

Worldwide Differences in Regulations of Clozapine Use.
Jimmi Nielsen, Corina Young, Petru Ifteni, Taishiro Kishimoto, Yu-Tao Xiang, Peter F J Schulte, Christoph U Correll, David Taylor. CNS Drugs 2016
91
33

Microdialysis evaluation of clozapine and N-desmethylclozapine pharmacokinetics in rat brain.
Thomas I F H Cremers, Gunnar Flik, Corry Hofland, Robert E Stratford. Drug Metab Dispos 2012
20
33

Triangulation in aetiological epidemiology.
Debbie A Lawlor, Kate Tilling, George Davey Smith. Int J Epidemiol 2016
411
33

Personalized Medicine and the Power of Electronic Health Records.
Noura S Abul-Husn, Eimear E Kenny. Cell 2019
64
33

Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update.
Elizabeth J Phillips, Chonlaphat Sukasem, Michelle Whirl-Carrillo, Daniel J Müller, Henry M Dunnenberger, Wasun Chantratita, Barry Goldspiel, Yuan-Tsong Chen, Bruce C Carleton, Alfred L George,[...]. Clin Pharmacol Ther 2018
113
33

The "Efficacy-Effectiveness Gap": Historical Background and Current Conceptualization.
Clementine Nordon, Helene Karcher, Rolf H H Groenwold, Mikkel Zöllner Ankarfeldt, Franz Pichler, Helene Chevrou-Severac, Michel Rossignol, Adeline Abbe, Lucien Abenhaim. Value Health 2016
60
33

Pharmacogenetics in Psychiatry: An Update on Clinical Usability.
Ron H N van Schaik, Daniel J Müller, Alessandro Serretti, Magnus Ingelman-Sundberg. Front Pharmacol 2020
23
33

Design and Early Implementation Successes and Challenges of a Pharmacogenetics Consult Clinic.
Meghan J Arwood, Eric A Dietrich, Benjamin Q Duong, D Max Smith, Kelsey Cook, Amanda Elchynski, Eric I Rosenberg, Katherine N Huber, Ying L Nagoshi, Ashleigh Wright,[...]. J Clin Med 2020
18
33

Essential Characteristics of Pharmacogenomics Study Publications.
Caroline F Thorn, Michelle Whirl-Carrillo, Houda Hachad, Julie A Johnson, Ellen M McDonagh, Mark J Ratain, Mary V Relling, Stuart A Scott, Russ B Altman, Teri E Klein. Clin Pharmacol Ther 2019
8
33

The interface of genomic information with the electronic health record: a points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
Theresa A Grebe, George Khushf, Margaret Chen, Dawn Bailey, Leslie Manace Brenman, Marc S Williams, Laurie H Seaver. Genet Med 2020
14
33

The efficacy and heterogeneity of antipsychotic response in schizophrenia: A meta-analysis.
Robert A McCutcheon, Toby Pillinger, Yuya Mizuno, Adam Montgomery, Haridha Pandian, Luke Vano, Tiago Reis Marques, Oliver D Howes. Mol Psychiatry 2021
21
33


Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles.
Jacqueline I Goldstein, L Fredrik Jarskog, Chris Hilliard, Ana Alfirevic, Laramie Duncan, Denis Fourches, Hailiang Huang, Monkol Lek, Benjamin M Neale, Stephan Ripke,[...]. Nat Commun 2014
103
33

Has increased provision of treatment reduced the prevalence of common mental disorders? Review of the evidence from four countries.
Anthony F Jorm, Scott B Patten, Traolach S Brugha, Ramin Mojtabai. World Psychiatry 2017
196
33

Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study.
John F Greden, Sagar V Parikh, Anthony J Rothschild, Michael E Thase, Boadie W Dunlop, Charles DeBattista, Charles R Conway, Brent P Forester, Francis M Mondimore, Richard C Shelton,[...]. J Psychiatr Res 2019
108
33

The Curious Neglect of High Functioning After Psychopathology: The Case of Depression.
Jonathan Rottenberg, Andrew R Devendorf, Todd B Kashdan, David J Disabato. Perspect Psychol Sci 2018
18
33

Global pharmacogenomics: where is the research taking us?
Catherine Olivier, Bryn Williams-Jones. Glob Public Health 2014
7
33

Antidepressant Outcomes Predicted by Genetic Variation in Corticotropin-Releasing Hormone Binding Protein.
Chloe P O'Connell, Andrea N Goldstein-Piekarski, Charles B Nemeroff, Alan F Schatzberg, Charles Debattista, Tania Carrillo-Roa, Elisabeth B Binder, Boadie W Dunlop, W Edward Craighead, Helen S Mayberg,[...]. Am J Psychiatry 2018
19
33

The identification of biomarkers predicting acute and maintenance lithium treatment response in bipolar disorder: A plea for further research attention.
Michele Fornaro, Domenico De Berardis, Annalisa Anastasia, Stefano Novello, Andrea Fusco, Carlo Ignazio Cattaneo, Marco Solmi, Francesco Monaco, Nicola Veronese, Yong-Ku Kim,[...]. Psychiatry Res 2018
14
33

Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine.
Domenico De Berardis, Gabriella Rapini, Luigi Olivieri, Domenico Di Nicola, Carmine Tomasetti, Alessandro Valchera, Michele Fornaro, Fabio Di Fabio, Giampaolo Perna, Marco Di Nicola,[...]. Ther Adv Drug Saf 2018
79
33

Peripheral biomarkers of major depression and antidepressant treatment response: Current knowledge and future outlooks.
Bharathi S Gadad, Manish K Jha, Andrew Czysz, Jennifer L Furman, Taryn L Mayes, Michael P Emslie, Madhukar H Trivedi. J Affect Disord 2018
58
33

Psychiatric genetic counseling: A mapping exercise.
Ramona Moldovan, Kevin A McGhee, Domenico Coviello, Anniken Hamang, Angela Inglis, Charlotta Ingvoldstad Malmgren, Maria Johansson-Soller, Mercy Laurino, Bettina Meiser, Lauren Murphy,[...]. Am J Med Genet B Neuropsychiatr Genet 2019
10
33

Dosing algorithms for vitamin K antagonists across VKORC1 and CYP2C9 genotypes.
E V Baranova, T I Verhoef, G Ragia, S le Cessie, F W Asselbergs, A de Boer, V G Manolopoulos, A H Maitland-van der Zee. J Thromb Haemost 2017
6
33

An assessment of the impact of pharmacogenomics on health disparities: a systematic literature review.
Antony Martin, Jennifer Downing, Michelle Maden, Nigel Fleeman, Ana Alfirevic, Alan Haycox, Munir Pirmohamed. Pharmacogenomics 2017
10
33




Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC).
Kelly E Caudle, Henry M Dunnenberger, Robert R Freimuth, Josh F Peterson, Jonathan D Burlison, Michelle Whirl-Carrillo, Stuart A Scott, Heidi L Rehm, Marc S Williams, Teri E Klein,[...]. Genet Med 2017
247
33

New drugs in psychiatry: focus on new pharmacological targets.
Filippo Caraci, Gian Marco Leggio, Salvatore Salomone, Filippo Drago. F1000Res 2017
14
33

Personalized Psychiatry and Depression: The Role of Sociodemographic and Clinical Variables.
Giampaolo Perna, Alessandra Alciati, Silvia Daccò, Massimiliano Grassi, Daniela Caldirola. Psychiatry Investig 2020
14
33


Pharmacometabolomics informs Pharmacogenomics.
Drew Neavin, Rima Kaddurah-Daouk, Richard Weinshilboum. Metabolomics 2016
28
33

Methodological and statistical issues in pharmacogenomics.
Bas J M Peters, Andrei S Rodin, Anthonius de Boer, Anke-Hilse Maitland-van der Zee. J Pharm Pharmacol 2010
19
33

Standardized Biogeographic Grouping System for Annotating Populations in Pharmacogenetic Research.
Rachel Huddart, Alison E Fohner, Michelle Whirl-Carrillo, Genevieve L Wojcik, Christopher R Gignoux, Alice B Popejoy, Carlos D Bustamante, Russ B Altman, Teri E Klein. Clin Pharmacol Ther 2019
41
33

Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test.
Sara T Brookes, Elise Whitely, Matthias Egger, George Davey Smith, Paul A Mulheran, Tim J Peters. J Clin Epidemiol 2004
429
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.